204 related articles for article (PubMed ID: 20180636)
1. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
Pozgan U; Caglic D; Rozman B; Nagase H; Turk V; Turk B
Biol Chem; 2010 May; 391(5):571-9. PubMed ID: 20180636
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
4. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
5. Cytochemical investigation of cathepsin B in rheumatoid synovial membrane and fluid.
Codorean E; Gabrielescu E
Morphol Embryol (Bucur); 1985; 31(4):269-74. PubMed ID: 2934623
[TBL] [Abstract][Full Text] [Related]
6. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
[TBL] [Abstract][Full Text] [Related]
7. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis.
Hashimoto Y; Kakegawa H; Narita Y; Hachiya Y; Hayakawa T; Kos J; Turk V; Katunuma N
Biochem Biophys Res Commun; 2001 May; 283(2):334-9. PubMed ID: 11327703
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.
Hummel KM; Petrow PK; Franz JK; Müller-Ladner U; Aicher WK; Gay RE; Brömme D; Gay S
J Rheumatol; 1998 Oct; 25(10):1887-94. PubMed ID: 9779840
[TBL] [Abstract][Full Text] [Related]
11. [Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis].
Itoh T; Uzuki M; Shimamura T; Sawai T
Ryumachi; 2002 Feb; 42(1):60-9. PubMed ID: 11925908
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
15. Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet's disease and familial Mediterranean fever?
Pay S; Erdem H; Serdar M; Dinç A; Simşek I; Turan M
Clin Rheumatol; 2002 Nov; 21(6):511-5. PubMed ID: 12447637
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis.
Simard N; Boire G; de Brum-Fernandes AJ; St-Pierre Y
Arthritis Res Ther; 2006; 8(4):R125. PubMed ID: 16859524
[TBL] [Abstract][Full Text] [Related]
17. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[TBL] [Abstract][Full Text] [Related]
18. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis.
Liu M; Sun H; Wang X; Koike T; Mishima H; Ikeda K; Watanabe T; Ochiai N; Fan J
Arthritis Rheum; 2004 Oct; 50(10):3112-7. PubMed ID: 15476203
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]